山河药辅增收不增利!董事长连年涨薪,大股东复星医药频繁减持套现

读创客户端
22 Apr

4月22日晚间,山河药辅(深市代码:300452)发布最新业绩。数据显示,该公司2024年实现营收8.83亿元,同比上升5.16%;归属于上市公司股东的净利润1.19亿元,同比下降26.07%。读创财经注意到,与净利下滑形成对比的是,山河药辅2024年高管总薪酬同比上涨82.2万元至477.43万元。其中,山河药辅董事长尹正龙年薪自公司上市后逐年上涨,2024年为98.82万元。资料显示,安徽山河...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10